Article Text

Download PDFPDF
2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer: Report From the Fourth Ovarian Cancer Consensus Conference
  1. Gavin C.E. Stuart, MD, FRCSC*,
  2. Henry Kitchener, MD,
  3. Monica Bacon, RN,
  4. Andreas duBois, MD, PhD§,
  5. Michael Friedlander, MD, PhD,
  6. Jonathan Ledermann, MD, FRCP,
  7. Christian Marth, MD, PhD,
  8. Tate Thigpen, MD, PhD# and
  9. Edward Trimble, MD**
  1. * NCIC-CTG, Canada;
  2. MRC/NCRI, UK;
  3. GCIG, Canada;
  4. § AGO-OVAR, Germany;
  5. ANZOG (Australia-New Zealand);
  6. AGO, Austria;
  7. # Gynecologic Oncology Group (GOG); and
  8. ** NCI-US.
  1. Address correspondence and reprint requests to Gavin C.E. Stuart, MD, FRCSC, University of British Columbia, 317-2194 Health Sciences Mall, Vancouver, BC, Canada V6T 1Z3. E-mail: gstuart{at}


2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer. This report provides the outcomes from the Fourth Ovarian Cancer Consensus Conference.

  • Ovarian cancer consensus conference
  • Gynecologic cancer intergroup

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.